Peripheral blood mononuclear cells from severe COVID-19 patients who are deficient in TLR7 genes do not respond to the in vitro application of IMQ, contrary to cell cultures from individuals with normal TLR7 genes [42]. This evidence concerns the gene TLR7 and COVID-19.